GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **2301 - 2325** of **4050** in total

« First

‹ Prev

…

89

90

91

92

93

94

95

96

97

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID	Arbitrary Fluorescence Units (AFU) ▼
IgM	Patient 1	22	moderate	G72739GY	164
IgG	Patient 2	15	mild	G68461PT	164
IgG	Patient 2	24	mild	G14988WV	164
IgM	Patient 2	3	mild	G82348BZ	164
IgM	Patient 3	11	mild	G25559RS	164
IgM	Patient 3	11	mild	G30839DN	164
IgM	Patient 4	12	mild	G00051MO	164
IgM	Patient 4	12	mild	G29857RC	164
IgG	Patient 1	6	moderate	G00066MO	163
IgM	Patient 4	12	mild	G21460SG	163
IgM	Patient 1	10	moderate	G60761LT	162
IgG	Patient 2	15	mild	G14988WV	162
IgM	Patient 2	15	mild	G63074CQ	162
IgG	Patient 3	4	mild	G41200QS	162
IgM	Patient 4	12	mild	G19118WX	162
IgM	Patient 1	22	moderate	G47566FL	161
IgM	Patient 3	-180	mild	G75896PD	161
IgM	Patient 3	4	mild	G09609EN	160
IgM	Patient 3	4	mild	G78255UI	160
IgG	Patient 1	22	moderate	G71142DF	159
IgG	Patient 2	24	mild	G68461PT	159
IgM	Patient 2	24	mild	G67045LB	159
IgG	Patient 2	3	mild	G71142DF	159
IgG	Patient 3	-180	mild	G47362BJ	159
IgM	Patient 4	12	mild	G82204SH	159